3O3D
Human Class I MHC HLA-A2 in complex with the Peptidomimetic ELA-2
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | APS BEAMLINE 19-BM |
Synchrotron site | APS |
Beamline | 19-BM |
Temperature [K] | 100 |
Wavelength(s) | 0.98 |
Spacegroup name | P 1 21 1 |
Unit cell lengths | 58.160, 84.244, 84.123 |
Unit cell angles | 90.00, 90.14, 90.00 |
Refinement procedure
Resolution | 20.000 - 1.700 |
R-factor | 0.18164 |
Rwork | 0.180 |
R-free | 0.21852 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 2gt9 |
RMSD bond length | 0.016 |
RMSD bond angle | 1.704 |
Data reduction software | HKL-2000 |
Data scaling software | HKL-2000 |
Phasing software | MOLREP |
Refinement software | REFMAC (5.5.0102) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 20.000 | 1.760 |
High resolution limit [Å] | 1.700 | 1.700 |
Rmerge | 0.910 | |
Number of reflections | 88669 | |
<I/σ(I)> | 14.9 | |
Completeness [%] | 99.4 | 98.3 |
Redundancy | 3.6 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 6.5 | 277 | PEG3350 24%, MES 0.025M, KCl 0.1M, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K |